Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

Interventricular septum metastasis in neuroendocrine tumour

Interventricular septum metastasis in neuroendocrine tumour Endocrine (2016) 53:870–871 DOI 10.1007/s12020-015-0712-9 ENDOCRINE IMAGING 1 1 1 • • Angelo Castello Vittorio Briganti Roberto Sciagra` Received: 12 May 2015 / Accepted: 31 July 2015 / Published online: 18 August 2015 Springer Science+Business Media New York 2015 A 50-year-old female during a visit at the internal medicine performed. Histology revealed a well-differentiated neu- department reported recurrent episodes of diarrhoea and roendocrine tumours (NET) with a Ki-67 proliferation flushing. Referred to the nuclear medicine department, she index\3 %. After 5 cycles of Lutetium-177 DOTATATE, underwent somatostatin receptor scintigraphy (SRS) of the somatostatin analogue treatment in association with ever- whole body and single photon-emission computed tomog- olimus was started. After 2 months, because of myelotox- raphy imaging of the abdomen and chest 24 h after injec- icity, everolimus was reduced to 5 mg. Echocardiography, tion of 200 MBq Indium-111 octreotide. SRS demonstrated repeated every 6 months, cardiac resonance and SRS, pathological tracer uptake in the pancreatic head, liver, performed every 12 months, confirmed no progression of ileum, 4th dorsal vertebra and in the cardiac region myocardial metastasis and stable disease after 4 years of (Fig. 1). Echocardiography and cardiac resonance imaging follow-up. confirmed a myocardial mass in the middle http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Endocrine Springer Journals

Interventricular septum metastasis in neuroendocrine tumour

Castello, Angelo; Briganti, Vittorio; Sciagrà, Roberto
Endocrine , Volume 53 (3) – Aug 18, 2015
Download PDF
2 pages

Loading next page...
 
/lp/springer-journals/interventricular-septum-metastasis-in-neuroendocrine-tumour-OaxtpXaxZ0

References (3)

Publisher
Springer Journals
Copyright
Copyright © 2015 by Springer Science+Business Media New York
Subject
Medicine & Public Health; Endocrinology; Diabetes; Internal Medicine; Science, general
ISSN
1355-008X
eISSN
1559-0100
DOI
10.1007/s12020-015-0712-9
pmid
26281000
Publisher site
See Article on Publisher Site

Abstract

Endocrine (2016) 53:870–871 DOI 10.1007/s12020-015-0712-9 ENDOCRINE IMAGING 1 1 1 • • Angelo Castello Vittorio Briganti Roberto Sciagra` Received: 12 May 2015 / Accepted: 31 July 2015 / Published online: 18 August 2015 Springer Science+Business Media New York 2015 A 50-year-old female during a visit at the internal medicine performed. Histology revealed a well-differentiated neu- department reported recurrent episodes of diarrhoea and roendocrine tumours (NET) with a Ki-67 proliferation flushing. Referred to the nuclear medicine department, she index\3 %. After 5 cycles of Lutetium-177 DOTATATE, underwent somatostatin receptor scintigraphy (SRS) of the somatostatin analogue treatment in association with ever- whole body and single photon-emission computed tomog- olimus was started. After 2 months, because of myelotox- raphy imaging of the abdomen and chest 24 h after injec- icity, everolimus was reduced to 5 mg. Echocardiography, tion of 200 MBq Indium-111 octreotide. SRS demonstrated repeated every 6 months, cardiac resonance and SRS, pathological tracer uptake in the pancreatic head, liver, performed every 12 months, confirmed no progression of ileum, 4th dorsal vertebra and in the cardiac region myocardial metastasis and stable disease after 4 years of (Fig. 1). Echocardiography and cardiac resonance imaging follow-up. confirmed a myocardial mass in the middle

Journal

Endocrine – Springer Journals

Published: Aug 18, 2015

There are no references for this article.